Blog
RSS FeedPosted by Michael Wonder on 19 Oct 2018
Competition watchdog’s appeal over Pfizer ruling dismissed
19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...
Posted by Michael Wonder on 19 Sep 2018
Truvada ruling could allow cheap HIV prevention in the UK
19 September 2018 - Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk ...
Posted by Michael Wonder on 04 May 2017
Another small victory for Australian Government in its pursuit of damages for PBS over-payments during interlocutory injunction period
4 May 2017 - The Australian Government has had another small victory in the most recent interlocutory decision in the clopidogrel ...
Posted by Michael Wonder on 20 Apr 2017
Full Federal Court confirms an application to list medicine on the PBS prior to patent expiry is a non-infringing act
19 April 2017 - Late last week, the Full Federal Court of Australia confirmed that the mere act of filing a ...
Posted by Michael Wonder on 26 Mar 2017
Federal Court of Australia dismisses preliminary discovery application regarding biosimilar suspected of infringing manufacturing process patents
26 March 2017 - In the recent decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis, Justice Stephen Burley of the Federal ...
Posted by Michael Wonder on 26 Apr 2016
TPP: no reason big pharma supply would stop
26 April 2016 - Trade Minister Todd McClay says he sees no reason why big pharmaceutical firms would stop supplying ...